129 related articles for article (PubMed ID: 16297632)
1. Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists.
Ohno M; Tanaka Y; Miyamoto M; Takeda T; Hoshi K; Yamada N; Ohtake A
Bioorg Med Chem; 2006 Mar; 14(6):2005-21. PubMed ID: 16297632
[TBL] [Abstract][Full Text] [Related]
2. Development of dual-acting benzofurans for thromboxane A2 receptor antagonist and prostacyclin receptor agonist: synthesis, structure-activity relationship, and evaluation of benzofuran derivatives.
Ohno M; Miyamoto M; Hoshi K; Takeda T; Yamada N; Ohtake A
J Med Chem; 2005 Aug; 48(16):5279-94. PubMed ID: 16078846
[TBL] [Abstract][Full Text] [Related]
3. Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Zhou D; Harrison BL; Shah U; Andree TH; Hornby GA; Scerni R; Schechter LE; Smith DL; Sullivan KM; Mewshaw RE
Bioorg Med Chem Lett; 2006 Mar; 16(5):1338-41. PubMed ID: 16332439
[TBL] [Abstract][Full Text] [Related]
4. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds.
Takeuchi K; Kohn TJ; True TA; Mais DE; Wikel JH; Utterback BG; Wyss VL; Jakubowski JA
J Med Chem; 1998 Dec; 41(27):5362-74. PubMed ID: 9876106
[TBL] [Abstract][Full Text] [Related]
5. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
[TBL] [Abstract][Full Text] [Related]
6. Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
Hoenke C; Bouyssou T; Tautermann CS; Rudolf K; Schnapp A; Konetzki I
Bioorg Med Chem Lett; 2009 Dec; 19(23):6640-4. PubMed ID: 19875286
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine derivatives.
Jiao PF; Zhao BX; Wang WW; He QX; Wan MS; Shin DS; Miao JY
Bioorg Med Chem Lett; 2006 Jun; 16(11):2862-7. PubMed ID: 16563757
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity.
Torrens A; Mas J; Port A; Castrillo JA; Sanfeliu O; Guitart X; Dordal A; Romero G; Fisas MA; Sánchez E; Hernández E; Pérez P; Pérez R; Buschmann H
J Med Chem; 2005 Mar; 48(6):2080-92. PubMed ID: 15771450
[TBL] [Abstract][Full Text] [Related]
9. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and optimization of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase.
Shreder KR; Cajica J; Du L; Fraser A; Hu Y; Kohno Y; Lin EC; Liu SJ; Okerberg E; Pham L; Wu J; Kozarich JW
Bioorg Med Chem Lett; 2009 Aug; 19(16):4743-6. PubMed ID: 19577470
[TBL] [Abstract][Full Text] [Related]
11. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
Kern JC; Terefenko EA; Fensome A; Unwallla R; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
Bioorg Med Chem Lett; 2007 Jan; 17(1):189-92. PubMed ID: 17027272
[TBL] [Abstract][Full Text] [Related]
12. 5,7,8-Trimethyl-benzopyran and 5,7,8-trimethyl-1,4-benzoxazine aminoamide derivatives as novel antiarrhythmics against ischemia-reperfusion injury.
Koini EN; Papazafiri P; Vassilopoulos A; Koufaki M; Horváth Z; Koncz I; Virág L; Papp GJ; Varró A; Calogeropoulou T
J Med Chem; 2009 Apr; 52(8):2328-40. PubMed ID: 19309156
[TBL] [Abstract][Full Text] [Related]
13. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists.
Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K
Bioorg Med Chem; 2007 Nov; 15(21):6692-704. PubMed ID: 17764960
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth.
Zhou XW; Ma HL; Zhang X; Jing SY; Miao JY; Zhao BX
Eur J Med Chem; 2014 May; 79():95-101. PubMed ID: 24727462
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioefficacy evaluation of new 3-substituted-3,4-dihydro-1,3-benzoxazines.
Shakil NA; Pandey A; Singh MK; Kumar J; Awasthi SK; Srivastava C; Singh MK; Pandey RP
J Environ Sci Health B; 2010 Feb; 45(2):108-15. PubMed ID: 20390939
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2-(4-substituted benzyl-1,4-diazepan-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.
Yang K; Sun LP; Liu JY; Cui X; Piao HR
Bioorg Med Chem Lett; 2010 Aug; 20(15):4464-7. PubMed ID: 20591664
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds with dual function.
Ilas J; Jakopin Z; Borstnar T; Stegnar M; Kikelj D
J Med Chem; 2008 Sep; 51(18):5617-29. PubMed ID: 18729445
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists.
Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K; Niwa T
Bioorg Med Chem Lett; 2007 Dec; 17(23):6588-92. PubMed ID: 17920266
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR studies of some [[1-aryl(or benzyl)-1-(benzenesulphonamido)methyl] phenyl] alkanoic acid derivatives as thromboxane A2 receptor antagonists.
Sairam KV; Sarma JA; Desiraju GR
Drug Des Discov; 2003; 18(2-3):47-51. PubMed ID: 14675942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
